Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies G Roberto, E Raschi, C Piccinni, V Conti, L Vignatelli, R D’Alessandro, ... Cephalalgia 35 (2), 118-131, 2015 | 163 | 2015 |
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy G Corrao, V Conti, L Merlino, AL Catapano, G Mancia Clinical therapeutics 32 (2), 300-310, 2010 | 119 | 2010 |
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation G Corrao, A Zambon, V Conti, F Nicotra, C La Vecchia, C Fornari, ... Annals of oncology 19 (1), 150-155, 2008 | 91 | 2008 |
Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies C Barbui, V Conti, A Cipriani Drug safety 37, 79-90, 2014 | 83 | 2014 |
Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches C Carnovale, V Conti, V Perrone, S Antoniazzi, M Pozzi, L Merlino, ... European journal of pediatrics 172, 1679-1685, 2013 | 51 | 2013 |
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions L Monaco, C Biagi, V Conti, M Melis, M Donati, M Venegoni, A Vaccheri, ... British journal of clinical pharmacology 83 (7), 1532-1543, 2017 | 50 | 2017 |
Paroxysmal sympathetic hyperactivity in pediatric rehabilitation: clinical factors and acute pharmacological management M Pozzi, V Conti, F Locatelli, S Galbiati, S Radice, G Citerio, E Clementi, ... The Journal of Head Trauma Rehabilitation 30 (5), 357-363, 2015 | 47 | 2015 |
Seriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization V Perrone, V Conti, M Venegoni, S Scotto, L Degli Esposti, D Sangiorgi, ... ClinicoEconomics and outcomes research, 505-514, 2014 | 44 | 2014 |
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on … G Corrao, L Scotti, A Zambon, G Baio, F Nicotra, V Conti, S Capri, ... Atherosclerosis 217 (2), 479-485, 2011 | 42 | 2011 |
One-year follow up of asthmatic patients newly initiated on treatment with medium-or high-dose inhaled corticosteroid-long-acting β2-agonist in UK primary care settings R Buhl, LG Heaney, E Loefroth, M Larbig, K Kostikas, V Conti, H Cao Respiratory medicine 162, 105859, 2020 | 36 | 2020 |
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders V Conti, A Lora, A Cipriani, I Fortino, L Merlino, C Barbui European journal of clinical pharmacology 68, 1647-1655, 2012 | 35 | 2012 |
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions C Biagi, V Conti, N Montanaro, M Melis, E Buccellato, M Donati, ... European journal of clinical pharmacology 70, 1505-1512, 2014 | 32 | 2014 |
Adequacy of treatment for patients with schizophrenia spectrum disorders and affective disorders in Lombardy, Italy A Lora, V Conti, O Leoni, AL Rivolta Psychiatric Services 62 (9), 1079-1084, 2011 | 31 | 2011 |
Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case–control study V Conti, M Venegoni, A Cocci, I Fortino, A Lora, C Barbui BMC psychiatry 15, 1-7, 2015 | 29 | 2015 |
Ethnic differences in the utilization of mental health services in Lombardy (Italy): an epidemiological analysis F Spinogatti, G Civenti, V Conti, A Lora Social psychiatry and psychiatric epidemiology 50, 59-65, 2015 | 28 | 2015 |
Differences in COPD exacerbation risk between women and men: analysis from the UK clinical practice research datalink data D Stolz, K Kostikas, E Loefroth, R Fogel, FS Gutzwiller, V Conti, H Cao, ... Chest 156 (4), 674-684, 2019 | 25 | 2019 |
Adherence to generic v. brand antidepressant treatment and the key role of health system factors C Barbui, V Conti Epidemiology and psychiatric sciences 24 (1), 23-26, 2015 | 25 | 2015 |
Paroxysmal sympathetic hyperactivity in pediatric rehabilitation: pathological features and scheduled pharmacological therapies M Pozzi, V Conti, F Locatelli, S Galbiati, S Radice, E Clementi, S Strazzer The Journal of Head Trauma Rehabilitation 32 (2), 117-124, 2017 | 23 | 2017 |
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey C Barbui, V Conti, M Purgato, A Cipriani, I Fortino, AL Rivolta, A Lora Epidemiology and psychiatric sciences 22 (4), 355-361, 2013 | 18 | 2013 |
Management of paroxysmal sympathetic hyperactivity with dexmedetomidine and propranolol following traumatic brain injury in a pediatric patient JW Branstetter, KL Ohman, DW Johnson, BW Gilbert Journal of Pediatric Intensive Care 9 (01), 064-069, 2020 | 16 | 2020 |